VIB Inks qBase+ Group Licensing Agreement with Biogazelle
Monday, May 20, 2013
VIB to accelerate its qPCR analyses by using qbase+ as the software.
GFT505 Reduces the Risk of Cardiovascular Events
Friday, May 17, 2013
Treatment with GFT505 significantly reduces the level of “remnant cholesterol”.
Curie-Cancer and Roche Strengthen Partnership
Friday, May 17, 2013
Curie-Cancer and Roche build on four years partnership by increasing translational research programs, speeding up development of new cancer treatments.
Nuvo Research Announces Scientific Presentation at the Annual Meeting of AAI
Friday, May 17, 2013
Data evaluating WF10's therapeutic impact on signs and symptoms of experimentally induced rheumatoid arthritis in mice.
Merck KGaA and Quintiles Announce Innovative Clinical Development Partnership
Friday, May 17, 2013
Agreement creates unique strategic collaboration for development and clinical trial execution.
Algeta: FDA Approves Xofigo (radium-223 dichloride)
Friday, May 17, 2013
Xofigo shown in a pivotal phase III trial to significantly improve overall survival.
AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease
Friday, May 17, 2013
First selective JAK1 inhibitor to enter Phase 2 studies in Crohn's disease.
Olink Bioscience Appoints Sigma-Aldrich as Distributor of Duolink
Friday, May 17, 2013
Olink Bioscience will continue to develop the protein biomarker market.
An International Vision for Wheat Improvement
Friday, May 17, 2013
By 2050, a 60% increase in wheat production will be needed to meet the demand of a growing population.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 1 - 10 of 22215 |
|
|
